查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587572

全基因測序市場規模、佔有率、趨勢分析報告：按產品/服務、按類型、按工作流程、按應用、按最終用途、按地區、細分市場預測，2025-2030

Whole Genome Sequencing Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables, Services), By Type, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

全基因測序市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球全基因測序市場規模預計將達到66.7億美元，2025年至2030年複合年成長率為22.17%。

市場成長的推動因素是基因組作圖計畫中擴大採用全基因測序以及遺傳疾病（包括罕見遺傳疾病）盛行率的增加。根據 2021 年 11 月發表在《新英格蘭醫學日誌》上的一項研究，全基因測序可能導致多種罕見疾病的早期診斷，報告了向精準醫學的轉變。

此外，增加對使用全基因組定序技術早期檢測和治療疾病的研發投資也有望推動市場成長。例如，2023年2月，印尼政府和基因組科學計畫獲得全球基金3,000萬美元投資，用於支持對抗COVID-19、結核病、癌症、遺傳疾病、腦部疾病和代謝性疾病等疾病我們建立了實施早期檢測和治療方法的設施網路。

全基因測序的應用範圍廣泛，政府機構正在採用這些技術對人類、植物、動物和微生物基因組序列測定，預計將推動市場成長。例如，美國食品藥物管理局（FDA）在不同國家食源性疾病爆發期間就採用了這種方法來識別食源性病原體。 FDA 自 2008 年起在其全基因測序(WGS) 計畫中採用了這項技術。這是因為它可以比脈衝場凝膠電泳 (PFGE) 更有效地識別所有食源性病原體菌株。

技術的不斷進步催生了創新全基因測序產品的推出，這些產品可以經濟、準確、及時地診斷各種疾病和感染疾病。這有助於市場的成長。例如，2022 年 12 月，LifeCell International Pvt. Ltd. 與 HaystackAnalytics 合作推出了 TB，這是一種全基因測序測試，旨在識別結核病感染的診斷資訊並應對抗藥性挑戰。

COVID-19 大流行增加了全球對該測試的需求，從而可以快速識別 SARS-CoV-2 並開發可能的診斷測試來控制疫情。因此，世界各國政府開始與研究機構和企業部門合作，利用這種方法來識別和診斷 SARS-CoV-2。幾家公司已經宣布了用於監測 SARS-CoV-2 病毒的基因組服務和快速解決方案。例如，QIAGEN 為 SARS-CoV-2 監測提供全基因測序服務，以識別有效變異、追蹤可能的疫情爆發並推進疫苗研究和藥物開發。

全基因測序市場報告亮點

  • 消耗品細分市場在 2024 年佔據最大佔有率，為 61.56%，原因是消耗品種類繁多，並且由於這些產品的保存期限較短而採用率不斷提高。
  • 從類型來看，大型全基因測序細分市場在2024年全基因測序市場中佔最大佔有率，達到77.32%。這是由於癌症腫瘤分析和罕見疾病基因突變識別等應用的不斷擴大。
  • 依工作流程分類，定序市場佔最大市場佔有率，2024年將達52.12%。這是由於領先公司的參與增加以及新產品的推出推動了該流程的採用。
  • 從應用來看，人類全基因測序領域在2024年佔據市場主導地位，佔有率為62.91%。這是由於罕見遺傳疾病的盛行率不斷上升，以及為查明這些疾病的致病因素而增加的研發投資。
  • 依最終用途分類，學術和研究機構領域主導全球市場，佔有率最大，達 48.72%。該細分市場的很大一部分是由於這些設施對高通量技術的需求不斷增加，以便在該領域進行全面的研究。
  • 北美地區佔比最大，2024年為51.34%。這一巨大佔有率是由於該地區擁有成熟的醫療保健系統和製藥行業，對用於臨床和研究目的的全基因測序產生了巨大的需求。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 遺傳疾病發生率增加
    • 降低基因序列分析的成本
    • 基因組作圖程式對全基因組序列分析的需求不斷增加
  • 市場限制因素分析
    • 與基因組定序相關的倫理和法律問題
  • 產業分析工具
    • 波特五力分析
    • 宏觀經濟分析
    • COVID-19 影響分析

第4章全基因測序市場：產品與服務的商業分析

  • 產品和服務細分儀表板
  • 全球全基因測序市場：產品與服務的變異分析
  • 2018-2030年全球全基因測序市場規模及產品與服務趨勢分析
  • 裝置
  • 消耗品
  • 服務

第5章全基因測序市場：類型業務分析

  • 類型細分儀表板
  • 全球全基因測序市場：類型變異分析
  • 2018-2030年全球全基因測序市場規模及趨勢分析（按類型）
  • 大規模全基因組定序
  • 小規模全基因組定序

第6章全基因測序市場：工作流程業務分析

  • 工作流程細分儀表板
  • 全球全基因測序市場：工作流程變化分析
  • 2018-2030 年全球全基因測序市場規模及趨勢分析（依工作流程）
  • 預測定序
  • 定序
  • 資料分析

第7章全基因測序市場：應用業務分析

  • 應用細分儀表板
  • 全球全基因測序市場：應用變異分析
  • 2018-2030年全球全基因測序市場規模及趨勢分析（依應用）
  • 人類全基因組序列分析
  • 植物全EXOME定序
  • 動物全EXOME定序
  • 微生物全EXOME定序

第8章全基因測序市場：最終用途業務分析

  • 最終用途細分儀表板
  • 全球全基因測序市場：最終用途變異分析
  • 2018-2030 年全球全基因測序市場規模及趨勢分析（依最終用途）
  • 學術研究所
  • 醫院/診所
  • 製藥和生物技術公司
  • 其他

第9章全基因測序市場：區域業務分析

  • 區域儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭格局

  • 參與企業
  • 策略規劃
  • 2024 年企業市場分析
  • 參與企業概況
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Oxford Nanopore Technologies
    • Pacific Biosciences of California, Inc.
    • BGI
    • QIAGEN
    • Agilent Technologies
    • ProPhase Labs, Inc.（Nebula Genomics）
    • Psomagen
    • Azenta US, Inc.（GENEWIZ）
Product Code: GVR-4-68040-037-0

Whole Genome Sequencing Market Growth & Trends:

The global whole genome sequencing market size is projected to reach USD 6.67 billion by 2030, expanding at a CAGR of 22.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising adoption of whole genome sequencing for genome mapping programs and the increasing prevalence of inherited disorders, including rare genetic disorders. According to the study published in the New England Journal of Medicine in November 2021, whole genome sequencing could lead to the early diagnosis of a wide range of rare diseases and a reported transition to precision medicine.

Furthermore, the growing investment in R&D for the early detection and treatment of disorders with the aid of WGS is expected to propel the growth of the market. For instance, in February 2023, the government of Indonesia and the Genome Science Initiative, with the aid of a USD 30 million investment from the Global Fund, established a network of facilities to perform the method for the early detection and treatment of disorders, including COVID-19, tuberculosis, cancer, genetic disorders, brain diseases, and metabolic disorders.

Whole genome sequencing has a wide range of applications, and government bodies are adopting these technologies for sequencing the genomes of humans, plant, animal, and microbes, which is expected to drive market growth. For instance, U.S. Food & Drug Administration (FDA) adopted the method to identify foodborne pathogens during foodborne disease outbreaks across the countries. The FDA has adopted this technology since 2008 under the Whole Genome Sequencing (WGS) program as it enables it to distinguish all strains of foodborne pathogens more efficiently than pulse-field gel electrophoresis (PFGE).

The rising technological advancements have led to the launch of innovative whole genome sequencing products that offer an affordable, accurate, and timely diagnosis of various diseases and infections. This is contributing to the growth of the market. For instance, in December 2022, LifeCell International Pvt. Ltd. collaborated with HaystackAnalytics to launch TB, a whole genome sequencing test to identify the diagnostic information on tuberculosis infections and tackle the drug resistance challenge.

The COVID-19 pandemic led to an increased demand for the method globally, which enabled the rapid identification of SARS-CoV-2 and the development of possible diagnostic tests to manage the outbreak. Hence, governments across the globe collaborated with research organizations and the corporate sector to use the method to identify and diagnose SARS-CoV-2. Several companies have launched genomic services and rapid solutions for the surveillance of the SARS-CoV-2 virus. For instance, QIAGEN offers the whole genome sequencing services SARS-CoV-2 surveillance for the identification of potent mutants, tracing of possible outbreaks, and advancement of vaccine research and drug development.

Whole Genome Sequencing Market Report Highlights:

  • Consumables segment held the largest share of 61.56% in 2024, owing to the availability of a wide range of consumables and increased adoption of these products due to the shorter duration of use of these products
  • By type, the large whole genome sequencing segment accounted for the largest share of 77.32% in the whole genome sequencing market in 2024. This can be attributed to the growing applications for analyzing cancerous tumors and identifying genetic variations in rare diseases
  • By workflow, the sequencing segment held the largest market share of 52.12% in 2024, owing to the growing involvement of major companies and the launch of novel products to boost the adoption of the process
  • By application, the human whole genome sequencing segment dominated the market in 2024 with a share of 62.91%. This can be attributed to the growing prevalence of rare inherited disorders and growing investment in R&D for the method to identify possible causative agents of these disorders
  • By end-use, the academic & research institutes segment dominated the global market with the largest share of 48.72%. The large share of the segment can be attributed to the growing demand for high-throughput technologies at these facilities to conduct comprehensive research in this field
  • North America held the largest market share of 51.34% in 2024. The large share can be attributed to the presence of a well-established healthcare system and pharmaceutical industry in the region, which has created a significant demand for whole genome sequencing for clinical and research purposes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Type Segment
    • 1.2.3. Workflow Segment
    • 1.2.4. Application Segment
    • 1.2.5. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Rising prevalence of inherited disorders
    • 3.2.2. Decreasing costs for genetic sequencing
    • 3.2.3. Rising demand for whole genome sequencing for genome mapping programs
  • 3.3. Market Restraint Analysis
    • 3.3.1. Ethical and legal challenges associated with genomic sequencing
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. Macroeconomic Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Whole Genome Sequencing Market: Product & Service Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Whole Genome Sequencing Market: Product & Service Movement Analysis
  • 4.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Whole Genome Sequencing Market: Type Business Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Global Whole Genome Sequencing Market: Type Movement Analysis
  • 5.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Large Whole Genome Sequencing
    • 5.4.1. Large Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 5.5. Small Whole Genome Sequencing
    • 5.5.1. Small Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 6. Whole Genome Sequencing Market: Workflow Business Analysis

  • 6.1. Workflow Segment Dashboard
  • 6.2. Global Whole Genome Sequencing Market: Workflow Movement Analysis
  • 6.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 6.4. Pre-Sequencing
    • 6.4.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
  • 6.5. Sequencing
    • 6.5.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 6.6. Data Analysis
    • 6.6.1. Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Whole Genome Sequencing Market: Application Business Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Whole Genome Sequencing Market: Application Movement Analysis
  • 7.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Human Whole Genome Sequencing
    • 7.4.1. Human Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.5. Plant Whole Exome Sequencing
    • 7.5.1. Plant Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.6. Animal Whole Exome Sequencing
    • 7.6.1. Animal Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.7. Microbial Whole Exome Sequencing
    • 7.7.1. Microbial Market, 2018 - 2030 (USD Million)

Chapter 8. Whole Genome Sequencing Market: End Use Business Analysis

  • 8.1. End use Segment Dashboard
  • 8.2. Global Whole Genome Sequencing Market: End use Movement Analysis
  • 8.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 8.4. Academic & Research Institutes
    • 8.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.5. Hospitals & Clinics
    • 8.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 8.6. Pharmaceutical & Biotechnology Companies
    • 8.6.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.7. Others
    • 8.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Whole Genome Sequencing Market: Regional Business Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. U.S. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Canada Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. Mexico Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Germany Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.3. UK
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. UK Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. France Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. Italy Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Spain Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Denmark Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Reimbursement Scenario
      • 9.4.8.6. Sweden Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Target Disease Prevalence
      • 9.4.9.3. Competitive Scenario
      • 9.4.9.4. Regulatory Framework
      • 9.4.9.5. Reimbursement Scenario
      • 9.4.9.6. Norway Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Japan Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. China Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. India Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Reimbursement Scenario
      • 9.5.5.6. South Korea Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Competitive Scenario
      • 9.5.6.4. Regulatory Framework
      • 9.5.6.5. Reimbursement Scenario
      • 9.5.6.6. Australia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.7. Thailand
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Competitive Scenario
      • 9.5.7.4. Regulatory Framework
      • 9.5.7.5. Reimbursement Scenario
      • 9.5.7.6. Thailand Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. Brazil Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Argentina Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Competitive Scenario
      • 9.7.2.4. Regulatory Framework
      • 9.7.2.5. Reimbursement Scenario
      • 9.7.2.6. South Africa Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Competitive Scenario
      • 9.7.3.4. Regulatory Framework
      • 9.7.3.5. Reimbursement Scenario
      • 9.7.3.6. Saudi Arabia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Target Disease Prevalence
      • 9.7.4.3. Competitive Scenario
      • 9.7.4.4. Regulatory Framework
      • 9.7.4.5. Reimbursement Scenario
      • 9.7.4.6. UAE Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Target Disease Prevalence
      • 9.7.5.3. Competitive Scenario
      • 9.7.5.4. Regulatory Framework
      • 9.7.5.5. Reimbursement Scenario
      • 9.7.5.6. Kuwait Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Participant's Overview
    • 10.4.1. Illumina, Inc.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product & Service Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product & Service Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Oxford Nanopore Technologies
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product & Service Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Pacific Biosciences of California, Inc.
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product & Service Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. BGI
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product & Service Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. QIAGEN
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product & Service Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Agilent Technologies
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product & Service Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. ProPhase Labs, Inc. (Nebula Genomics)
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product & Service Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Psomagen
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product & Service Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Azenta US, Inc. (GENEWIZ)
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product & Service Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Global whole genome sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 11 North America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 12 North America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 13 North America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 14 North America whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 U.S. whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 16 U.S. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 17 U.S. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 U.S. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.S. whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Canada whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Canada whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 22 Canada whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Canada whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 24 Canada whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Mexico whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Mexico whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 28 Mexico whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 29 Mexico whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Europe whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 31 Europe whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 32 Europe whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 33 Europe whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 34 Europe whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 35 Europe whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 36 UK whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 37 UK whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 38 UK whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 UK whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 40 UK whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Germany whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Germany whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 43 Germany whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 44 Germany whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 45 Germany whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 46 France whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 47 France whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 48 France whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 49 France whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 50 France whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Italy whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 52 Italy whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 53 Italy whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 Italy whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Italy whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Spain whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 57 Spain whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Spain whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 59 Spain whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 60 Spain whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Denmark whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 62 Denmark whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Denmark whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 64 Denmark whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Denmark whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Sweden whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 Sweden whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 68 Sweden whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Sweden whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 70 Sweden whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Norway whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 Norway whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 73 Norway whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 74 Norway whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 75 Norway whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Japan whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 83 Japan whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 84 Japan whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 85 Japan whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 86 Japan whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 87 China whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 88 China whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 89 China whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 90 China whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 91 China whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 92 India whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 93 India whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 94 India whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 95 India whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 96 India whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Australia whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 98 Australia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 99 Australia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Australia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 101 Australia whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Thailand whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 103 Thailand whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 104 Thailand whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 105 Thailand whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 106 Thailand whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 107 South Korea whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 108 South Korea whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 109 South Korea whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Korea whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Korea whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Latin America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 113 Latin America whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 114 Latin America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 115 Latin America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 116 Latin America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 117 Latin America whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Brazil whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 119 Brazil whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 120 Brazil whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 121 Brazil whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 122 Brazil whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Argentina whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 124 Argentina whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 125 Argentina whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 126 Argentina whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 127 Argentina whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 134 South Africa whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 135 South Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 136 South Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 137 South Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 138 South Africa whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 144 UAE whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 145 UAE whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 146 UAE whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 147 UAE whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 148 UAE whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 150 Kuwait whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 152 Kuwait whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products/services
  • Table 160 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Whole genome sequencing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Whole genome sequencing market: Porter's analysis
  • Fig. 15 Whole genome sequencing market: PESTLE analysis
  • Fig. 16 Whole genome sequencing market: Product & service outlook and key takeaways
  • Fig. 17 Whole genome sequencing market: Product & service movement analysis, 2024 - 2030
  • Fig. 18 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 19 Global consumables market, 2018 - 2030 (USD Million)
  • Fig. 20 Global services market, 2018 - 2030 (USD Million)
  • Fig. 21 Whole genome sequencing market: Type outlook and key takeaways
  • Fig. 22 Whole genome sequencing market: Type movement analysis, 2024 - 2030
  • Fig. 23 Global large whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 24 Global small whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 25 Whole genome sequencing market: Workflow outlook and key takeaways
  • Fig. 26 Whole genome sequencing market: Workflow movement analysis, 2024 - 2030
  • Fig. 27 Global pre-sequencing market, 2018 - 2030 (USD Million)
  • Fig. 28 Global sequencing market, 2018 - 2030 (USD Million)
  • Fig. 29 Global data analysis market, 2018 - 2030 (USD Million)
  • Fig. 30 Whole genome sequencing market: Application outlook and key takeaways
  • Fig. 31 Whole genome sequencing market: Application movement analysis, 2024 - 2030
  • Fig. 32 Global human whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 33 Global plant whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 34 Global animal whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 35 Global microbial whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 36 Whole genome sequencing market: End use outlook and key takeaways
  • Fig. 37 Whole genome sequencing market: End use movement analysis, 2024 - 2030
  • Fig. 38 Global academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 39 Global hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 40 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 41 Global others market, 2018 - 2030 (USD Million)
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. key country dynamics
  • Fig. 45 U.S. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Canada key country dynamics
  • Fig. 47 Canada whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico key country dynamics
  • Fig. 49 Mexico whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 UK key country dynamics
  • Fig. 52 UK whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Germany key country dynamics
  • Fig. 54 Germany whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 France key country dynamics
  • Fig. 56 France whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Italy key country dynamics
  • Fig. 58 Italy whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Spain key country dynamics
  • Fig. 60 Spain whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Denmark key country dynamics
  • Fig. 62 Denmark whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden key country dynamics
  • Fig. 64 Sweden whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Norway key country dynamics
  • Fig. 66 Norway whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Asia-Pacific whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 China key country dynamics
  • Fig. 71 China whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 India key country dynamics
  • Fig. 73 India whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Australia key country dynamics
  • Fig. 75 Australia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Thailand key country dynamics
  • Fig. 77 Thailand whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 South Korea key country dynamics
  • Fig. 79 South Korea whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil key country dynamics
  • Fig. 82 Brazil whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Argentina key country dynamics
  • Fig. 84 Argentina whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 MEA whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa key country dynamics
  • Fig. 87 South Africa whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia key country dynamics
  • Fig. 89 Saudi Arabia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 UAE key country dynamics
  • Fig. 91 UAE whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait key country dynamics
  • Fig. 93 Kuwait whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Key company categorization
  • Fig. 95 Company market position analysis, 2024
  • Fig. 96 Market participant categorization
  • Fig. 97 Strategy framework